News

New Wahl ad campaign celebrates ‘real guys’ living their dreams

BY Antoinette Alexander

STERLING, Ill.  — Wahl Clipper is launching new documentary-style ads as part of a continuation of its “Real Guys. Real Grooming.” campaign, which began last year with a spotlight on the Clinton LumberKings minor league baseball players in Iowa who were chasing their dreams. This time around, Wahl is turning the cameras on modern-day cowboys and craft brewers who are living their dreams.  


The TV spots began airing nationwide on Monday on more than 10 major networks — including ESPN, NFL and Spike — and will run throughout October and November. The campaign also is supported by digital advertising, event marketing, social media and earned media.

While the campaign is about real guys living their dreams, it’s also about how grooming — as in the right tools and achieving the right look — fits into their journeys. This approach appears to be hitting the mark, as sales of Wahl trimmers and clippers have increased more than 10% over the past year, the company stated.

“Guys today are looking for real, relatable and inspirational,” said Steven Yde, director of marketing for Wahl. “Our “Real Guys. Real Grooming.” campaign is a celebration of everyday guys who are achieving their dreams and want to look good without a lot of fuss. It’s honest, authentic and empowering with a slice of Americana on the side — all things that have come to define Wahl over the last 95 years.”


The “Real Guys. Real Grooming.” campaign was developed by HY Connect, an integrated advertising agency with offices in Chicago and Milwaukee. The campaign landing page, WahlRealGuys.com, features the ads, documentary videos, hair and facial hair styles, beard and beer pairings and product information.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Par begins shipping generic Exforge tabs

BY Ryan Chavis

WOODCLIFF LAKE, N.J. — Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths. The tablets are the generic version of Exforge from Novartis and are used to treat hypertension. 
 
The tablets also are indicated to lower blood pressure in patients not controlled on monotherapy and as initial therapy in patients who likely need multiple drugs to achieve their blood-pressure goals, the company stated. U.S. sales of Exforge totaled approximately $422 million, according to IMS Health data. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Salix, Progenics announce FDA approval for Relistor

BY Ryan Chavis

RALEIGH, N.C. and TARRYTOWN, N.Y. — Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain. The drug currently is the only available medication approved for treating opioid-induced constipation at the cause without interfering with the properties of the opioid, the companies said. 
 
“Frequently, opioid analgesics are prescribed to manage pain in patients suffering from chronic conditions. Unfortunately, the use of an opioid can result in debilitating constipation for a significant number of these patients,” said Bill Forbes, EVP, medical, research and development and chief development officer, Salix. “The approval and availability of Relistor for treating the underlying cause of OIC provides an important and welcomed advancement for many patients who experience constipation while taking opioids for chronic non-cancer pain.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?